Market Tracker

06/29 12:24pm ET

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

2.50
Delayed Data
As of 12:07pm ET
 -0.19 / -7.06%
Today’s Change
1.26
Today|||52-Week Range
6.49
-34.55%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close2.69
Today’s open2.64
Day’s range2.46 - 2.66
Volume20,419
Average volume (3 months)63,619
Market cap$17.6M
Dividend yield--
Data as of 12:07pm ET, 06/29/2016

Growth & Valuation

Earnings growth (last year)+73.42%
Earnings growth (this year)+29.52%
Earnings growth (next 5 years)--
Revenue growth (last year)-52.11%
P/E ratioNM
Price/Sales558.44
Price/Book1.98

Competitors

 Today’s
change
Today’s
% change
BPMXBiopharmx Corp+0.06+9.32%
CSBRChampions Oncology I...+0.04+1.82%
WGBSWaferGen Bio-systems...-0.00-0.24%
SNGXSoligenix Inc-0.04-5.22%
Data as of 12:08pm ET, 06/29/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$34.0K
Annual profit (last year)-$10.2M
Net profit margin-30,067.65%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Marlborough, Massachusetts

Forecasts